MeMed: Valuation, Funding & Investors
MeMed is a diagnostics company focused on host-response testing that translates immune system signals into clinical insights for acute and infectious diseases. The company develops rapid, FDA-grade host-response tests and AI-enabled diagnostics (AIVD) to distinguish bacterial from viral infections and predict severe outcomes, and is building an acute-care biobank and proteomics platform to support AI-driven diagnostic development.
Leadership & Board
- Current Number of Employees
- 97
- Current LinkedIn Followers
- 22,323
Latest Estimated Valuation
- Total Amount Raised
- $2M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $2M
- Latest Funding Round
- Investment
Company Momentum
PositiveMeMed LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
MeMed had 97 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
MeMed had 22,323 followers as of November 16, 2026. The number of followers increased by 44 (0.20%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 12, 2026 | Investment | $2.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Israel Innovation Authority | Investment |
Similar Companies
A snapshot of private companies similar to MeMed, helping you discover and navigate related company profiles.




